Conference Coverage

New research holds promise for fighting obesity, says expert


 

AT INTERNAL MEDICINE 2022

Medication costs are too high for many patients

Isis Smith, MD, an internist at University Medical Center in New Orleans, said in an interview that the cost of the most effective medications – which are not covered by Medicaid – means that many of her patients don’t have access to these treatments.

“We’re talking about $1,000 a month. And so there is no way they can afford [them]. I can prescribe phentermine [but] unless a patient has another indication, Medicaid will not pay for it,” she explained.

“I love hearing about all of the new developments. ... It’s interesting to hear, but we need to get insurance to pay so that I can actually prescribe,” Dr. Smith noted.

Dr. Apovian reports financial relationships with Xeno Biosciences, Cowen, Allergan, Novo Nordisk, Abbott Nutrition, and other companies.

Pages

Recommended Reading

Intermittent fasting good for weight loss, at least short term
MDedge Cardiology
Sleep deprivation sends fat to the belly
MDedge Cardiology
FDA okays semaglutide higher dose, 2 mg/week, for type 2 diabetes
MDedge Cardiology
Be aware of gallbladder, biliary disease with newer obesity drugs
MDedge Cardiology
Hypertension control during pregnancy validated in major trial
MDedge Cardiology
Type 2 diabetes remission possible for those with lower BMI
MDedge Cardiology
AHA statement addresses CVD risk in NAFLD
MDedge Cardiology
Bariatric surgery cuts cardiovascular events, even in seniors
MDedge Cardiology
It’s time to shame the fat shamers
MDedge Cardiology
Tirzepatide succeeds in obesity in SURMOUNT-1, says Lilly
MDedge Cardiology